ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding ProMIS Neurosciences Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 17 | 17 | 0 |
| Shares | 9.72M | 9.31M | −403.2K (−4.1%) |
| Value | $9.21M | $6.49M | −$2.72M (−29.5%) |
New holders (1)
Institutions that held ProMIS Neurosciences Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Abound Wealth Management | 1 | $1 | 0.00% |
Sold out (1)
Institutions that held ProMIS Neurosciences Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Sandy Spring Bank | 3,300 | $3.13K |